Literature DB >> 23503465

DNA damage emergency: cellular garbage disposal to the rescue?

H R Stone1, J R Morris1.   

Abstract

The proteasome is a cellular machine found in the cytosol, nucleus and on chromatin that performs much of the proteolysis in eukaryotic cells. Recent reports show it is enriched at sites of double-stranded DNA breaks (DSBs) in mammalian cells. What is it doing there? This review will address three possibilities suggested by recent reports: in degrading proteins after their ubiquitination at and eviction from chromatin; as a deubiquitinase, specific to the antagonism of ubiquitin conjugates generated as part of the signalling of a DSB; and as a functional component of DNA repair mechanism itself. These findings add complexity to the proteasome as a potential therapeutic target in cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23503465     DOI: 10.1038/onc.2013.60

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

Review 1.  Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect.

Authors:  Shiwu Zhang; Chuanwei Yang; Zhenduo Yang; Dan Zhang; Xiaoping Ma; Gordon Mills; Zesheng Liu
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 2.  Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect.

Authors:  Shiwu Zhang; Chuanwei Yang; Zhenduo Yang; Dan Zhang; Xiaoping Ma; Gordon Mills; Zesheng Liu
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

3.  Decarbamoyl mitomycin C (DMC) activates p53-independent ataxia telangiectasia and rad3 related protein (ATR) chromatin eviction.

Authors:  Gu Xiao; Pao Kue; Rahul Bhosle; Jill Bargonetti
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  iRhom1 regulates proteasome activity via PAC1/2 under ER stress.

Authors:  WonJae Lee; YoungDoo Kim; Jisu Park; SangMi Shim; Jieun Lee; Se-hoon Hong; Hye-Hyun Ahn; Huikyong Lee; Yong-Keun Jung
Journal:  Sci Rep       Date:  2015-06-25       Impact factor: 4.379

5.  Downregulation of ubiquitin inhibits the proliferation and radioresistance of non-small cell lung cancer cells in vitro and in vivo.

Authors:  Yiting Tang; Yangyang Geng; Judong Luo; Wenhao Shen; Wei Zhu; Cuicui Meng; Ming Li; Xifa Zhou; Shuyu Zhang; Jianping Cao
Journal:  Sci Rep       Date:  2015-03-30       Impact factor: 4.379

6.  Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted therapy.

Authors:  Esmee Koedoot; Liesanne Wolters; Marcel Smid; Peter Stoilov; Gerhard A Burger; Bram Herpers; Kuan Yan; Leo S Price; John W M Martens; Sylvia E Le Dévédec; Bob van de Water
Journal:  Sci Rep       Date:  2021-03-31       Impact factor: 4.379

7.  LEDGF/p75 Is Required for an Efficient DNA Damage Response.

Authors:  Victoria Liedtke; Christian Schröder; Dirk Roggenbuck; Romano Weiss; Ralf Stohwasser; Peter Schierack; Stefan Rödiger; Lysann Schenk
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

Review 8.  DNA damage and regulation of protein homeostasis.

Authors:  Tanya T Paull
Journal:  DNA Repair (Amst)       Date:  2021-06-08

9.  Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to doxorubicin-induced apoptosis.

Authors:  Hao Wang; Yang Yu; Zheng Jiang; Wen-Ming Cao; Zhenyu Wang; Jun Dou; Yanling Zhao; Yunfu Cui; Hong Zhang
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

Review 10.  Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks.

Authors:  Han Yang; Shuling Ren; Siyuan Yu; Haifeng Pan; Tingdong Li; Shengxiang Ge; Jun Zhang; Ningshao Xia
Journal:  Int J Mol Sci       Date:  2020-09-04       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.